LONDON (AP) — The European Medicines Agency said a smaller dose of the monkeypox vaccine appears to still be effective and can be used to stretch the current supply by five times, echoing a recommendation made earlier this month by the U.S. Food and Drug Administration. In a statement on Friday, the EU drug regulator said injecting people with just one fifth the regular dose of the smallpox vaccine made by Bavarian Nordic appeared to be equally protective. The approach calls for administering Bavarian Nordic’s vaccine with an injection just under the skin rather than into deeper tissue, which may stimulate a better immune response.